HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.
3rd Edition of
International Ophthalmology Conference
March 10-12, 2025 | Rome, Italy
Keratoprosthetics
Keratoprosthetics
Keratoprosthetics implantation entails removing the cornea to its full thickness and replacing it with an artificial cornea. The discovery of antibiotics and the introduction of novel materials in the last century breathed new life into the discipline. Since then, the usage of keratoprostheses for severe ocular surface disorders and corneal opacities has skyrocketed, to the point where it is now considered a common operation by corneal experts all over the world. The basic principle of replacing a damaged and opaque cornea with an artificial cornea, or keratoprosthetics, is as simple as putting a window in a house to be able to see out.
- Global Scenario of Keratoprosthetics
- Research on Keratoprosthetics
Committee Members
John David Bullock
Wright State University, United States
Minckler Don S
UCI Gavin Herbert Eye Institute, United States
Kasra Rezaei
University of Washington, United States IOC 2025 Speakers
Dhruva Drew Gupta
Harvard Medical School, United States
Nour Abou Shousha
Harvard Medical School, United States
George HH Beiko
McMaster Univeresity, Canada
Mustafa Al Ghazi
University Hospital of Wales, United KingdomSubmit your abstract Today
Title : Eyes and guts connection: Microbiomes and their role in ocular health
Edward Charles Kondrot, Healing the Eye Wellness Center, United States
Title : Optic nerve orthograde axonal transport in abusive head trauma suspects
Minckler Don S, UCI Gavin Herbert Eye Institute, United States
Title : Why was Leonhard Euler blind?
John David Bullock, Wright State University, United States
Title : A factorial randomized controlled trial of tissue plasminogen activator and/or perfluoropropane for the treatment of submacular hemorrhage secondary to neovascular age-related macular degeneration (TAPAS)
Tim Jackson, King’s College London, United Kingdom
Title : Monovision cataract surgery made simple
Shadrokh Nabili, University Hospitals of Morecambe Bay NHS Foundation Trust, United Kingdom
Title : An innovative in vitro human-based millifluidic platform as useful tool to underlying mechanisms of neurodegeneration in glaucoma
Anna Maria Bassi, University of Genoa, Italy